Peripheral neuropathy in colorectal cancer survivors: The influence of oxaliplatin administration. Results from the population-based PROFILES registry
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Peripheral neuropathy in colorectal cancer survivors: The influence of oxaliplatin administration. Results from the population-based PROFILES registry
Authors
Keywords
-
Journal
ACTA ONCOLOGICA
Volume 54, Issue 4, Pages 463-469
Publisher
Informa UK Limited
Online
2014-11-24
DOI
10.3109/0284186x.2014.980912
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A systematic review on chronic oxaliplatin-induced peripheral neuropathy and the relation with oxaliplatin administration
- (2014) A. J. M. Beijers et al. SUPPORTIVE CARE IN CANCER
- Chemotherapy-induced peripheral neuropathy and its association with quality of life: a systematic review
- (2014) Floortje Mols et al. SUPPORTIVE CARE IN CANCER
- Diminishing differences in treatment between patients with colorectal cancer with and without diabetes: a population-based study
- (2013) M. M. J. Zanders et al. DIABETIC MEDICINE
- Chemotherapy-Induced Neuropathy and Its Association With Quality of Life Among 2- to 11-Year Colorectal Cancer Survivors: Results From the Population-Based PROFILES Registry
- (2013) Floortje Mols et al. JOURNAL OF CLINICAL ONCOLOGY
- Peripheral neurotoxicity of oxaliplatin in combination with 5-fluorouracil (FOLFOX) or capecitabine (XELOX): a prospective evaluation of 150 colorectal cancer patients
- (2012) A. A. Argyriou et al. ANNALS OF ONCOLOGY
- Clinical pattern and associations of oxaliplatin acute neurotoxicity
- (2012) Andreas A. Argyriou et al. CANCER
- The NaV1.7 sodium channel: from molecule to man
- (2012) Sulayman D. Dib-Hajj et al. NATURE REVIEWS NEUROSCIENCE
- Gain-of-function Nav1.8 mutations in painful neuropathy
- (2012) C. G. Faber et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Gain of function NaV1.7 mutations in idiopathic small fiber neuropathy
- (2011) Catharina G. Faber et al. ANNALS OF NEUROLOGY
- The Patient Reported Outcomes Following Initial treatment and Long term Evaluation of Survivorship registry: Scope, rationale and design of an infrastructure for the study of physical and psychosocial outcomes in cancer survivorship cohorts
- (2011) Lonneke V. van de Poll-Franse et al. EUROPEAN JOURNAL OF CANCER
- Long-Term Neuropathy After Oxaliplatin Treatment: Challenging the Dictum of Reversibility
- (2011) S. B. Park et al. ONCOLOGIST
- Dose Effects of Oxaliplatin on Persistent and Transient Na+ Conductances and the Development of Neurotoxicity
- (2011) Susanna B. Park et al. PLoS One
- Capecitabine combined with oxaliplatin (CapOx) in clinical practice: how significant is peripheral neuropathy?
- (2010) D. J. Storey et al. ANNALS OF ONCOLOGY
- Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/leucovorin plus oxaliplatin (FOLFOX-6) as first-line treatment for metastatic colorectal cancer
- (2010) Michel Ducreux et al. INTERNATIONAL JOURNAL OF CANCER
- Improved Overall Survival With Oxaliplatin, Fluorouracil, and Leucovorin As Adjuvant Treatment in Stage II or III Colon Cancer in the MOSAIC Trial
- (2009) Thierry André et al. JOURNAL OF CLINICAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started